| |
NewswireTODAY - /newswire/ -
Seoul, Korea (South), 2010/08/11 - NOVACELL Technology in collaboration with Kollodis BioSciences, Inc. (USA) introduced new lines of MAPTrix™ ECM-based protective and anti-aging skincare products which include a facial mask, eye patch, UV sun cream, and cleaning oil - NovaCellTech.com.
|
| |
The new line of MAPTrix™ ECM-based cosmeceutical products are recombinantly engineered skincare products that help clients rejuvenate their skin. An additional bioactive peptide called W3 bio-peptide is also included in the skincare products for skin whitening and anti-wrinkle effects. The cosmeceutical skincare products are being launched under the "LAAC" brand name.
NOVACELL Technology received clearance from the CTFA (Cosmetic, Toiletry, and Fragrance Association) for MAPTrix™ ECM and W3 peptides as substances applied to the skin in March of 2010; and, both MAPTrix™ ECM and W3 are currently registered in the International Cosmetic Ingredient Dictionary (ICID).
“We have finished the installation of the manufacture line and have now entered the sales phase. We are confident that the cosmeceutical market will find our LAAC products as an exciting alternative to existing cosmeceutical products currently on the market. Our novel skincare offerings combine the latest advances in skincare technology to help our clients rejuvenate their skin.” said Taehoon Lee, the President and CEO of NOVACELL Technology.
MAPTrix™ ECM is a next generation bioactive cosmetic ingredient that will command attention in the cosmetic industry as collagen has in the past, stated Dr. Lee. He also stated that NOVACELL will continue to make all efforts to grow this prospective ingredient to continuously feed various product lines of cosmeceuticals for use in the global cosmetic market.
“The extracellular matrix (ECM) of the skin’s dermis - which contains key biologically active ingredients for skin rejuvenation - is composed primarily of Type-I collagen, fibronectin and related proteins. MAPTrix™ ECM (recombinantly engineered protein products) can offer a similar composition as the naturally occurring ECM for skin regeneration and maintenance. The successful launch of LAAC demonstrates that Kollodis BioSciences' MAPTrix™ ECM is an effective ingredient for tissue regeneration and winkle improvement”, said Dr. Louis M. Scarmoutzos, Chief Executive Officer of Kollodis BioSciences.
About NOVACELL Technology Inc.
NOVACELL Technology (novacelltech.com) was established in 2000 by fellow researchers and professors of Pohang University of Science and Technology (POSTECH) as a bio-venture company specializing in proteomics technology, protein analytical services, peptide library screening, stem-cell growth and differentiation control technology. NOVACELL Technology has been actively providing contract research services for new drug development as well as conducting collaborative research products with various other domestic (South Korea) and foreign universities, research labs, and institutions. NOVACELL has recently launched the MAPTrix™ based premium cosmeceutical products and is now actively engaging in strategic partnerships, technology transfer and co-development to prepare the Company for an initial public offering in KOSDAQ in 2011 as well as efforts to become a global bio-venture company.
About Kollodis BioSciences, Inc.
Kollodis BioSciences, Inc. (kollodis.com) has successfully developed a proprietary recombinant protein expression system for the large scale production of various mussel adhesive proteins (MAP). Kollodis is dedicated to the development, manufacture, and sale of MAP-based smart biomaterials for biotech, medical and industrial applications. The Company's proprietary and patented MAPTrix™ ECM platform technology recombinantly incorporates bioactive peptides into a mussel adhesive protein (MAP) for cell culture and related applications.
|
taehoon[.]postech.ac.kr 
